<DOC>
	<DOCNO>NCT01273857</DOCNO>
	<brief_summary>Hypoplastic leave heart syndrome ( HLHS ) relate anomaly involve single ventricle characterize hypoplasia leave heart aorta compromise systemic cardiac output . Infants syndrome generally undergo staged surgical approach view ultimate Fontan procedure . Although long-term survival patient HLHS relate single ventricle physiology improve markedly advance medical surgical therapy , grow number infant ultimately require heart transplantation end-stage heart failure due several potential disadvantage include negative effect right ventricular function , arrhythmia , additional volume load via regurgitation nonvalved shunt , impaired growth pulmonary artery . Risk factor poor outcome heart transplantation HLHS single ventricle physiology old age transplantation previous Fontan operation . New strategy need improve underlie transplant risk proper Fontan failure patient . Emerging evidence suggest heart-derived stem/progenitor cell use improved cardiac function patient ischemic heart disease . In trial , investigator aim test safety feasibility intracoronary injection autologous cardiac progenitor cell patient HLHS relate single ventricle anomaly could improve ventricular function 3 month ' follow .</brief_summary>
	<brief_title>Transcoronary Infusion Cardiac Progenitor Cells Patients With Single Ventricle Physiology</brief_title>
	<detailed_description>Autologous cardiac progenitor cell isolated patient ' cardiac tissue obtain palliative shunt procedure . Patients receive 0.3 million/kg autologous cardiac progenitor cell via intracoronary delivery 1 month cardiac surgery . Follow-up visit 3 month 1 year cell injection need prospectively verify clinical , laboratory , safety-related data .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
	<criteria>Infants hypoplastic leave heart syndrome relate single ventricle anomaly undergo first third palliative shunt surgery recruit study . Patients 0 6 year age eligible write informed consent obtain . Cardiogenic shock Eisenmenger syndrome Uncontrollable arrhythmia Severe chronic disease Infections Cancer Unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Cardiac progenitor cell</keyword>
	<keyword>Cell therapy</keyword>
	<keyword>Hypoplastic Left Heart Syndrome</keyword>
	<keyword>Single Ventricle</keyword>
	<keyword>Norwood</keyword>
	<keyword>Sano modification</keyword>
	<keyword>Glenn</keyword>
	<keyword>Fontan</keyword>
</DOC>